{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:50:00Z","timestamp":1793235000982,"version":"4.5.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82203031"],"award-info":[{"award-number":["82203031"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32200154"],"award-info":[{"award-number":["32200154"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-02841-6","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T16:03:00Z","timestamp":1726502580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["The progress and future of the treatment of Candida albicans infections based on nanotechnology"],"prefix":"10.1186","volume":"22","author":[{"given":"Yang","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingpeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingtong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"key":"2841_CR1","first-page":"1","volume":"4","author":"PG Pappas","year":"2018","unstructured":"Pappas PG, Lionakis MS, Arendrup MC, Ostrosky-Zeichner L, Kullberg BJ. Invasive candidiasis. Nat Reviews Disease Primers. 2018;4:1\u201320.","journal-title":"Nat Reviews Disease Primers"},{"key":"2841_CR2","doi-asserted-by":"crossref","unstructured":"Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild MJ, Bohlius J, et al. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect. 2019;25:1200\u201312.","DOI":"10.1016\/j.cmi.2019.04.024"},{"key":"2841_CR3","doi-asserted-by":"publisher","first-page":"13250","DOI":"10.1111\/tid.13250","volume":"22","author":"SM Hosseini-Moghaddam","year":"2020","unstructured":"Hosseini-Moghaddam SM, Ou\u00e9draogo A, Naylor KL, Bota SE, Husain S, Nash DM, Paterson JM. Incidence and outcomes of invasive fungal infection among solid organ transplant recipients: a population\u2010based cohort study. Transpl Infect Disease. 2020;22:13250.","journal-title":"Transpl Infect Disease"},{"key":"2841_CR4","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S1473-3099(23)00692-8","volume":"24","author":"DW Denning","year":"2024","unstructured":"Denning DW. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024;24:428\u201338.","journal-title":"Lancet Infect Dis"},{"key":"2841_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.trsl.2022.04.002","volume":"247","author":"N Liu","year":"2022","unstructured":"Liu N, Zhou J, Jiang T, Tarsio M, Yu F, Zheng X, Qi W, Liu L, Tan J, Wei L, et al. A dual action small molecule enhances azoles and overcomes resistance through co-targeting Pdr5 and Vma1: Osimertinib targets Pdr5 and Vma1. Translational Research: J Lab Clin Med. 2022;247:39\u201357.","journal-title":"Translational Research: J Lab Clin Med"},{"key":"2841_CR6","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.trsl.2022.04.002","volume":"247","author":"N-N Liu","year":"2022","unstructured":"Liu N-N, Zhou J, Jiang T, Tarsio M, Yu F, Zheng X, Qi W, Liu L, Tan J-c, Wei L. A dual action small molecule enhances azoles and overcomes resistance through co-targeting Pdr5 and Vma1. Translational Res. 2022;247:39\u201357.","journal-title":"Translational Res"},{"key":"2841_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S0966-842X(01)02094-7","volume":"9","author":"RA Calderone","year":"2001","unstructured":"Calderone RA, Fonzi WA. Virulence factors of Candida albicans. Trends Microbiol. 2001;9:327\u201335.","journal-title":"Trends Microbiol"},{"key":"2841_CR8","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1093\/clinids\/20.6.1531","volume":"20","author":"RP Wenzel","year":"1995","unstructured":"Wenzel RP. Nosocomial candidemia: risk factors and attributable mortality. Clin Infect Dis. 1995;20:1531\u20134.","journal-title":"Clin Infect Dis"},{"key":"2841_CR9","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","volume":"10","author":"DA Enoch","year":"2017","unstructured":"Enoch DA, Yang H, Aliyu SH, Micallef C. The changing epidemiology of invasive fungal infections. Hum Fungal Pathogen Identification: Methods Protocols. 2017;10:17\u201365.","journal-title":"Hum Fungal Pathogen Identification: Methods Protocols"},{"key":"2841_CR10","doi-asserted-by":"publisher","first-page":"a019703","DOI":"10.1101\/cshperspect.a019703","volume":"4","author":"T Roemer","year":"2014","unstructured":"Roemer T, Krysan DJ. Antifungal drug development: challenges, unmet clinical needs, and new approaches. Cold Spring Harbor Perspect Med. 2014;4:a019703.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"2841_CR11","first-page":"17","volume":"2","author":"T Lombardi","year":"1993","unstructured":"Lombardi T, Budtz-J\u00f8rgensen E. Treatment of denture-induced stomatitis: a review. Eur J Prosthodont Restor Dent. 1993;2:17\u201322.","journal-title":"Eur J Prosthodont Restor Dent"},{"key":"2841_CR12","first-page":"51","volume":"30","author":"JE Nett","year":"2016","unstructured":"Nett JE, Andes DR. Antifungal agents: spectrum of activity, pharmacology, and clinical indications. Infect Disease Clin. 2016;30:51\u201383.","journal-title":"Infect Disease Clin"},{"key":"2841_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1128\/AAC.44.2.368-377.2000","volume":"44","author":"J Onishi","year":"2000","unstructured":"Onishi J, Meinz M, Thompson J, Curotto J, Dreikorn S, Rosenbach M, Douglas C, Abruzzo G, Flattery A, Kong L. Discovery of novel antifungal (1, 3)-\u03b2-D-glucan synthase inhibitors. Antimicrob Agents Chemother. 2000;44:368\u201377.","journal-title":"Antimicrob Agents Chemother"},{"key":"2841_CR14","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1345\/aph.1R020","volume":"46","author":"ND Beyda","year":"2012","unstructured":"Beyda ND, Lewis RE, Garey KW. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches. Ann Pharmacother. 2012;46:1086\u201396.","journal-title":"Ann Pharmacother"},{"key":"2841_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41579-022-00720-1","volume":"20","author":"MC Fisher","year":"2022","unstructured":"Fisher MC, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell EM, Bowyer P, Bromley M, Br\u00fcggemann R, Garber G, Cornely OA. Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022;20:557\u201371.","journal-title":"Nat Rev Microbiol"},{"key":"2841_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micres.2007.08.001","volume":"163","author":"RF Donnelly","year":"2008","unstructured":"Donnelly RF, McCarron PA, Tunney MM. Antifungal photodynamic therapy. Microbiol Res. 2008;163:1\u201312.","journal-title":"Microbiol Res"},{"key":"2841_CR17","doi-asserted-by":"publisher","first-page":"e1002870","DOI":"10.1371\/journal.ppat.1002870","volume":"8","author":"A Butts","year":"2012","unstructured":"Butts A, Krysan DJ. Antifungal drug discovery: something old and something new. PLoS Pathog. 2012;8:e1002870.","journal-title":"PLoS Pathog"},{"key":"2841_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","volume":"76","author":"NR Stone","year":"2016","unstructured":"Stone NR, Bicanic T, Salim R, Hope W. Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions. Drugs. 2016;76:485\u2013500.","journal-title":"Drugs"},{"key":"2841_CR19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMoa2111904","volume":"386","author":"JN Jarvis","year":"2022","unstructured":"Jarvis JN, Lawrence DS, Meya DB, Kagimu E, Kasibante J, Mpoza E, Rutakingirwa MK, Ssebambulidde K, Tugume L, Rhein J. Single-dose liposomal amphotericin B treatment for cryptococcal meningitis. N Engl J Med. 2022;386:1109\u201320.","journal-title":"N Engl J Med"},{"key":"2841_CR20","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1016\/j.apsb.2023.05.018","volume":"13","author":"Q Liu","year":"2023","unstructured":"Liu Q, Zou J, Chen Z, He W, Wu W. Current research trends of nanomedicines. Acta Pharm Sinica B. 2023;13:4391\u2013416.","journal-title":"Acta Pharm Sinica B"},{"key":"2841_CR21","first-page":"1570","volume":"10","author":"A Leenders","year":"1996","unstructured":"Leenders A, Marie S. The use of lipid formulations of amphotericin B for systemic fungal infections. Leukemia. 1996;10:1570\u20135.","journal-title":"Leukemia"},{"key":"2841_CR22","doi-asserted-by":"publisher","first-page":"1902913","DOI":"10.1002\/advs.201902913","volume":"7","author":"S Cheeseman","year":"2020","unstructured":"Cheeseman S, Christofferson AJ, Kariuki R, Cozzolino D, Daeneke T, Crawford RJ, Truong VK, Chapman J, Elbourne A. Antimicrobial metal nanomaterials: from passive to stimuli-activated applications. Adv Sci. 2020;7:1902913.","journal-title":"Adv Sci"},{"key":"2841_CR23","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1080\/1040841X.2020.1803208","volume":"46","author":"VHS Araujo","year":"2020","unstructured":"Araujo VHS, Duarte JL, Carvalho GC, Silvestre ALP, Fonseca-Santos B, Marena GD, Ribeiro TC, dos Santos Ramos MA, Bauab TM, Chorilli M. Nanosystems against candidiasis: a review of studies performed over the last two decades. Crit Rev Microbiol. 2020;46:508\u201347.","journal-title":"Crit Rev Microbiol"},{"key":"2841_CR24","doi-asserted-by":"publisher","first-page":"813973","DOI":"10.3389\/fchem.2021.813973","volume":"9","author":"B Li","year":"2021","unstructured":"Li B, Pan L, Zhang H, Xie L, Wang X, Shou J, Qi Y, Yan X. Recent developments on using nanomaterials to combat Candida albicans. Front Chem. 2021;9:813973.","journal-title":"Front Chem"},{"key":"2841_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","volume":"9","author":"Y Huang","year":"2024","unstructured":"Huang Y, Guo X, Wu Y, Chen X, Feng L, Xie N, Shen G. Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal Transduct Target Therapy. 2024;9:34.","journal-title":"Signal Transduct Target Therapy"},{"key":"2841_CR26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41579-023-00905-2","volume":"21","author":"V Choi","year":"2023","unstructured":"Choi V, Rohn JL, Stoodley P, Carugo D, Stride E. Drug delivery strategies for antibiofilm therapy. Nat Rev Microbiol. 2023;21:555\u201372.","journal-title":"Nat Rev Microbiol"},{"key":"2841_CR27","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1365-2672.2007.03299.x","volume":"103","author":"G DeQueiroz","year":"2007","unstructured":"DeQueiroz G, Day D. Antimicrobial activity and effectiveness of a combination of sodium hypochlorite and hydrogen peroxide in killing and removing Pseudomonas aeruginosa biofilms from surfaces. J Appl Microbiol. 2007;103:794\u2013802.","journal-title":"J Appl Microbiol"},{"key":"2841_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41579-019-0322-2","volume":"18","author":"J Berman","year":"2020","unstructured":"Berman J, Krysan DJ. Drug resistance and tolerance in fungi. Nat Rev Microbiol. 2020;18:319\u201331.","journal-title":"Nat Rev Microbiol"},{"key":"2841_CR29","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.mi.41.100187.002251","volume":"41","author":"JW Costerton","year":"1987","unstructured":"Costerton JW, Cheng K, Geesey GG, Ladd TI, Nickel JC, Dasgupta M, Marrie TJ. Bacterial biofilms in nature and disease. Annual Reviews Microbiol. 1987;41:435\u201364.","journal-title":"Annual Reviews Microbiol"},{"key":"2841_CR30","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","volume":"284","author":"JW Costerton","year":"1999","unstructured":"Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284:1318\u201322.","journal-title":"Science"},{"key":"2841_CR31","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s11892-006-0076-x","volume":"6","author":"SC Davis","year":"2006","unstructured":"Davis SC, Martinez L, Kirsner R. The diabetic foot: the importance of biofilms and wound bed preparation. Curr Diab Rep. 2006;6:439\u201345.","journal-title":"Curr Diab Rep"},{"key":"2841_CR32","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.addr.2005.04.007","volume":"57","author":"AW Smith","year":"2005","unstructured":"Smith AW. Biofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems? Adv Drug Deliv Rev. 2005;57:1539\u201350.","journal-title":"Adv Drug Deliv Rev"},{"key":"2841_CR33","doi-asserted-by":"publisher","first-page":"5385","DOI":"10.1128\/JB.183.18.5385-5394.2001","volume":"183","author":"J Chandra","year":"2001","unstructured":"Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol. 2001;183:5385\u201394.","journal-title":"J Bacteriol"},{"key":"2841_CR34","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1128\/AAC.00227-10","volume":"54","author":"JE Nett","year":"2010","unstructured":"Nett JE, Crawford K, Marchillo K, Andes DR. Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob Agents Chemother. 2010;54:3505\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"2841_CR35","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1128\/AAC.48.9.3291-3297.2004","volume":"48","author":"MA Al-Fattani","year":"2004","unstructured":"Al-Fattani MA, Douglas LJ. Penetration of Candida biofilms by antifungal agents. Antimicrob Agents Chemother. 2004;48:3291\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"2841_CR36","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1093\/cid\/cis021","volume":"54","author":"DR Andes","year":"2012","unstructured":"Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin Infect Dis. 2012;54:1110\u201322.","journal-title":"Clin Infect Dis"},{"key":"2841_CR37","first-page":"35","volume":"48","author":"C Liu","year":"2021","unstructured":"Liu C, Wu H, Xu K. Photodynamic therapy and the application of antitumor immunotherapy for tumor treatment. Zhongguo Zhong Liu Lin Chuang. 2021;48:35\u20139.","journal-title":"Zhongguo Zhong Liu Lin Chuang"},{"key":"2841_CR38","doi-asserted-by":"publisher","first-page":"1900608","DOI":"10.1002\/adhm.201900608","volume":"8","author":"Q Jia","year":"2019","unstructured":"Jia Q, Song Q, Li P, Huang W. Rejuvenated photodynamic therapy for bacterial infections. Adv Healthc Mater. 2019;8:1900608.","journal-title":"Adv Healthc Mater"},{"key":"2841_CR39","doi-asserted-by":"publisher","first-page":"12129","DOI":"10.1021\/acsnano.1c03508","volume":"15","author":"C Zhou","year":"2021","unstructured":"Zhou C, Peng C, Shi C, Jiang M, Chau JH, Liu Z, Bai H, Kwok RT, Lam JW, Shi Y. Mitochondria-specific aggregation-induced emission luminogens for selective photodynamic killing of fungi and efficacious treatment of keratitis. ACS Nano. 2021;15:12129\u201339.","journal-title":"ACS Nano"},{"key":"2841_CR40","doi-asserted-by":"publisher","first-page":"4357","DOI":"10.1021\/acsomega.2c07740","volume":"8","author":"N Tang","year":"2023","unstructured":"Tang N, Yuan S, Luo Y, Wang A-J, Sun K, Liu N-N, Tao K. Nanoparticle-based photodynamic inhibition of Candida albicans Biofilms with Interfering Quorum sensing. ACS Omega. 2023;8:4357\u201368.","journal-title":"ACS Omega"},{"key":"2841_CR41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3390\/jof6030099","volume":"6","author":"R Kov\u00e1cs","year":"2020","unstructured":"Kov\u00e1cs R, Majoros L. Fungal quorum-sensing molecules: a review of their antifungal effect against Candida biofilms. J Fungi. 2020;6:99.","journal-title":"J Fungi"},{"key":"2841_CR42","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/php.12733","volume":"93","author":"I Maliszewska","year":"2017","unstructured":"Maliszewska I, Lisiak B, Popko K, Matczyszyn K. Enhancement of the efficacy of photodynamic inactivation of Candida albicans with the use of biogenic gold nanoparticles. Photochem Photobiol. 2017;93:1081\u201390.","journal-title":"Photochem Photobiol"},{"key":"2841_CR43","doi-asserted-by":"publisher","first-page":"101733","DOI":"10.1016\/j.jsps.2023.101733","volume":"31","author":"OA Madkhali","year":"2023","unstructured":"Madkhali OA. A comprehensive review on potential applications of metallic nanoparticles as antifungal therapies to combat human fungal diseases. Saudi Pharm J. 2023;31:101733.","journal-title":"Saudi Pharm J"},{"key":"2841_CR44","doi-asserted-by":"publisher","first-page":"10066","DOI":"10.1021\/acsnano.2c02269","volume":"16","author":"X Zhao","year":"2022","unstructured":"Zhao X, Tang H, Jiang X. Deploying gold nanomaterials in combating multi-drug-resistant bacteria. ACS Nano. 2022;16:10066\u201387.","journal-title":"ACS Nano"},{"key":"2841_CR45","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3390\/md21020123","volume":"21","author":"N Tabassum","year":"2023","unstructured":"Tabassum N, Khan F, Kang M-G, Jo D-M, Cho K-J, Kim Y-M. Inhibition of Polymicrobial Biofilms of Candida albicans\u2013Staphylococcusaureus\/Streptococcus mutans by Fucoidan\u2013Gold Nanoparticles. Mar Drugs. 2023;21:123.","journal-title":"Mar Drugs"},{"key":"2841_CR46","doi-asserted-by":"publisher","first-page":"2206437","DOI":"10.1002\/adma.202206437","volume":"34","author":"J He","year":"2022","unstructured":"He J, Ye Y, Zhang D, Yao K, Zhou M. Visualized Gallium\/Lyticase-Integrated Antifungal Strategy for Fungal Keratitis Treatment. Adv Mater. 2022;34:2206437.","journal-title":"Adv Mater"},{"key":"2841_CR47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrd.2017.46","volume":"16","author":"JR Perfect","year":"2017","unstructured":"Perfect JR. The antifungal pipeline: a reality check. Nat Rev Drug Discovery. 2017;16:603\u201316.","journal-title":"Nat Rev Drug Discovery"},{"key":"2841_CR48","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nchembio.1496","volume":"10","author":"TM Anderson","year":"2014","unstructured":"Anderson TM, Clay MC, Cioffi AG, Diaz KA, Hisao GS, Tuttle MD, Nieuwkoop AJ, Comellas G, Maryum N, Wang S. Amphotericin forms an extramembranous and fungicidal sterol sponge. Nat Chem Biol. 2014;10:400\u20136.","journal-title":"Nat Chem Biol"},{"key":"2841_CR49","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/jac\/dkg117","volume":"51","author":"V Letscher-Bru","year":"2003","unstructured":"Letscher-Bru V, Herbrecht R. Caspofungin: the first representative of a new antifungal class. J Antimicrob Chemother. 2003;51:513\u201321.","journal-title":"J Antimicrob Chemother"},{"key":"2841_CR50","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1021\/acs.chemrev.0c00199","volume":"121","author":"Y Lee","year":"2020","unstructured":"Lee Y, Puumala E, Robbins N, Cowen LE. Antifungal drug resistance: molecular mechanisms in Candida albicans and beyond. Chem Rev. 2020;121:3390\u2013411.","journal-title":"Chem Rev"},{"key":"2841_CR51","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1038\/s41467-018-06944-1","volume":"9","author":"J Gao","year":"2018","unstructured":"Gao J, Wang H, Li Z, Wong AH-H, Wang Y-Z, Guo Y, Lin X, Zeng G, Liu H, Wang Y. Candida albicans gains azole resistance by altering sphingolipid composition. Nat Commun. 2018;9:4495.","journal-title":"Nat Commun"},{"key":"2841_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"A Lemke","year":"2005","unstructured":"Lemke A, Kiderlen A, Kayser O. Amphotericin b. Appl Microbiol Biotechnol. 2005;68:151\u201362.","journal-title":"Appl Microbiol Biotechnol"},{"key":"2841_CR53","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1021\/acsnano.0c01665","volume":"14","author":"L Rao","year":"2020","unstructured":"Rao L, Tian R, Chen X. Cell-membrane-mimicking nanodecoys against infectious diseases. ACS Nano. 2020;14:2569\u201374.","journal-title":"ACS Nano"},{"key":"2841_CR54","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jconrel.2020.09.012","volume":"327","author":"P Dash","year":"2020","unstructured":"Dash P, Piras AM, Dash M. Cell membrane coated nanocarriers-an efficient biomimetic platform for targeted therapy. J Controlled Release. 2020;327:546\u201370.","journal-title":"J Controlled Release"},{"key":"2841_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1049\/mnl.2015.0108","volume":"11","author":"Y Liu","year":"2019","unstructured":"Liu Y, Luo J, Chen X, Liu W, Chen T. Cell membrane coating technology: a promising strategy for biomedical applications. Nano-Micro Lett. 2019;11:1\u201346.","journal-title":"Nano-Micro Lett"},{"key":"2841_CR56","doi-asserted-by":"crossref","unstructured":"Xie J, Shen Q, Huang K, Zheng T, Cheng L, Zhang Z, et al. Oriented assembly of cell-mimicking nanoparticles via a molecular affinity strategy for targeted drug delivery. ACS Nano. 2019;13:5268\u201377.","DOI":"10.1021\/acsnano.8b09681"},{"key":"2841_CR57","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41565-024-01618-0","volume":"19","author":"B Li","year":"2024","unstructured":"Li B, Wang W, Zhao L, Wu Y, Li X, Yan D, Gao Q, Yan Y, Zhang J, Feng Y. Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles. Nat Nanotechnol. 2024;19:834\u201345.","journal-title":"Nat Nanotechnol"},{"key":"2841_CR58","doi-asserted-by":"crossref","unstructured":"Zhu J, Xie R, Gao R, Zhao Y, Yodsanit N, Zhu M, et al. Multimodal nanoimmunotherapy engages neutrophils to eliminate Staphylococcus aureus infections. Nat Nanotechnol 2024;19:1032\u201343.","DOI":"10.1038\/s41565-024-01648-8"},{"key":"2841_CR59","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.it.2021.08.005","volume":"42","author":"ME Deerhake","year":"2021","unstructured":"Deerhake ME, Shinohara ML. Emerging roles of Dectin-1 in noninfectious settings and in the CNS. Trends Immunol. 2021;42:891\u2013903.","journal-title":"Trends Immunol"},{"key":"2841_CR60","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nri1745","volume":"6","author":"GD Brown","year":"2006","unstructured":"Brown GD. Dectin-1: a signalling non-TLR pattern-recognition receptor. Nat Rev Immunol. 2006;6:33\u201343.","journal-title":"Nat Rev Immunol"},{"key":"2841_CR61","first-page":"e00025","volume":"4","author":"S Ambati","year":"2019","unstructured":"Ambati S, Ferarro AR, Kang SE, Lin J, Lin X, Momany M, Lewis ZA, Meagher RB. Dectin-1-targeted antifungal liposomes exhibit enhanced efficacy. MSphere. 2019;4:e00025\u201300019.","journal-title":"MSphere"},{"key":"2841_CR62","doi-asserted-by":"publisher","first-page":"114006","DOI":"10.1016\/j.addr.2021.114006","volume":"179","author":"N Krishnan","year":"2021","unstructured":"Krishnan N, Fang RH, Zhang L. Engineering of stimuli-responsive self-assembled biomimetic nanoparticles. Adv Drug Deliv Rev. 2021;179:114006.","journal-title":"Adv Drug Deliv Rev"},{"key":"2841_CR63","doi-asserted-by":"publisher","first-page":"2312939","DOI":"10.1002\/adma.202312939","volume":"36","author":"M Fatima","year":"2024","unstructured":"Fatima M, Almalki WH, Khan T, Sahebkar A, Kesharwani P. Harnessing the power of Stimuli-Responsive nanoparticles as an effective therapeutic drug delivery system. Adv Mater. 2024;36:2312939.","journal-title":"Adv Mater"},{"key":"2841_CR64","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jconrel.2017.04.023","volume":"256","author":"S-C Park","year":"2017","unstructured":"Park S-C, Kim Y-M, Lee J-K, Kim N-H, Kim E-J, Heo H, Lee M-Y, Lee JR, Jang M-K. Targeting and synergistic action of an antifungal peptide in an antibiotic drug-delivery system. J Controlled Release. 2017;256:46\u201355.","journal-title":"J Controlled Release"},{"key":"2841_CR65","doi-asserted-by":"publisher","first-page":"121249","DOI":"10.1016\/j.biomaterials.2021.121249","volume":"280","author":"Z Wang","year":"2022","unstructured":"Wang Z, Liu X, Duan Y, Huang Y. Infection microenvironment-related antibacterial nanotherapeutic strategies. Biomaterials. 2022;280:121249.","journal-title":"Biomaterials"},{"key":"2841_CR66","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/jid.2012.399","volume":"133","author":"AJ Friedman","year":"2013","unstructured":"Friedman AJ, Phan J, Schairer DO, Champer J, Qin M, Pirouz A, Blecher-Paz K, Oren A, Liu PT, Modlin RL. Antimicrobial and anti-inflammatory activity of chitosan\u2013alginate nanoparticles: a targeted therapy for cutaneous pathogens. J Invest Dermatology. 2013;133:1231\u20139.","journal-title":"J Invest Dermatology"},{"key":"2841_CR67","doi-asserted-by":"publisher","first-page":"123354","DOI":"10.1016\/j.ijbiomac.2023.123354","volume":"231","author":"EM Khalaf","year":"2023","unstructured":"Khalaf EM, Abood NA, Atta RZ, Ram\u00edrez-Coronel AA, Alazragi R, Parra RMR, Abed OH, Abosaooda M, Jalil AT, Mustafa YF. Recent progressions in biomedical and pharmaceutical applications of chitosan nanoparticles: a comprehensive review. Int J Biol Macromol. 2023;231:123354.","journal-title":"Int J Biol Macromol"},{"key":"2841_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijvsm.2017.02.003","volume":"5","author":"M Mohamed","year":"2017","unstructured":"Mohamed M, Fouad S, Elshoky HA, Mohammed GM, Salaheldin TA. Antibacterial effect of gold nanoparticles against Corynebacterium pseudotuberculosis. Int J Veterinary Sci Med. 2017;5:23\u20139.","journal-title":"Int J Veterinary Sci Med"},{"key":"2841_CR69","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s40820-015-0040-x","volume":"7","author":"A Sirelkhatim","year":"2015","unstructured":"Sirelkhatim A, Mahmud S, Seeni A, Kaus NHM, Ann LC, Bakhori SKM, Hasan H, Mohamad D. Review on Zinc Oxide nanoparticles: antibacterial activity and toxicity mechanism. Nano-Micro Lett. 2015;7:219\u201342.","journal-title":"Nano-Micro Lett"},{"key":"2841_CR70","doi-asserted-by":"publisher","first-page":"14813","DOI":"10.1038\/srep14813","volume":"5","author":"M Arakha","year":"2015","unstructured":"Arakha M, Pal S, Samantarrai D, Panigrahi TK, Mallick BC, Pramanik K, Mallick B, Jha S. Antimicrobial activity of iron oxide nanoparticle upon modulation of nanoparticle-bacteria interface. Sci Rep. 2015;5:14813.","journal-title":"Sci Rep"},{"key":"2841_CR71","doi-asserted-by":"crossref","unstructured":"Kubacka A, Diez MS, Rojo D, Bargiela R, Ciordia S, Zapico I, et al. Understanding the antimicrobial mechanism of TiO2-based nanocomposite films in a pathogenic bacterium. Sci Rep 2014;4:4134.","DOI":"10.1038\/srep04134"},{"key":"2841_CR72","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.2147\/IJN.S150648","volume":"13","author":"VS Radhakrishnan","year":"2018","unstructured":"Radhakrishnan VS, Mudiam MKR, Kumar M, Dwivedi SP, Singh SP, Prasad T. Silver nanoparticles induced alterations in multiple cellular targets, which are critical for drug susceptibilities and pathogenicity in fungal pathogen (Candida albicans). Int J Nanomed. 2018;13:2647.","journal-title":"Int J Nanomed"},{"key":"2841_CR73","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s40097-020-00331-3","volume":"10","author":"M Ashrafi","year":"2020","unstructured":"Ashrafi M, Bayat M, Mortazavi P, Hashemi SJ, Meimandipour A. Antimicrobial effect of chitosan\u2013silver\u2013copper nanocomposite on Candida albicans. J Nanostructure Chem. 2020;10:87\u201395.","journal-title":"J Nanostructure Chem"},{"key":"2841_CR74","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ijbiomac.2019.08.199","volume":"140","author":"A Youssef","year":"2019","unstructured":"Youssef A, Abd El-Aziz M, Abd El-Sayed ES, Moussa M, Turky G, Kamel S. Rational design and electrical study of conducting bionanocomposites hydrogel based on chitosan and silver nanoparticles. Int J Biol Macromol. 2019;140:886\u201394.","journal-title":"Int J Biol Macromol"},{"key":"2841_CR75","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2174\/092986710790416290","volume":"17","author":"L Zhang","year":"2010","unstructured":"Zhang L, Pornpattananangkul D, Hu C-M, Huang C-M. Development of nanoparticles for antimicrobial drug delivery. Curr Med Chem. 2010;17:585\u201394.","journal-title":"Curr Med Chem"},{"key":"2841_CR76","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jconrel.2011.07.002","volume":"156","author":"AJ Huh","year":"2011","unstructured":"Huh AJ, Kwon YJ. Nanoantibiotics: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Controlled Release. 2011;156:128\u201345.","journal-title":"J Controlled Release"},{"key":"2841_CR77","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.chembiol.2016.06.016","volume":"23","author":"BM Vincent","year":"2016","unstructured":"Vincent BM, Langlois J-B, Srinivas R, Lancaster AK, Scherz-Shouval R, Whitesell L, Tidor B, Buchwald SL, Lindquist S. A fungal-selective cytochrome bc1 inhibitor impairs virulence and prevents the evolution of drug resistance. Cell Chem Biology. 2016;23:978\u201391.","journal-title":"Cell Chem Biology"},{"key":"2841_CR78","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1086\/320876","volume":"33","author":"JH Rex","year":"2001","unstructured":"Rex JH, Walsh TJ, Nettleman M, Anaissie EJ, Bennett JE, Bow EJ, Carillo-Munoz A, Chavanet P, Cloud GA, Denning DW. Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses. Clin Infect Dis. 2001;33:95\u2013106.","journal-title":"Clin Infect Dis"},{"key":"2841_CR79","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.aap7999","volume":"360","author":"MC Fisher","year":"2018","unstructured":"Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science. 2018;360:739\u201342.","journal-title":"Science"},{"key":"2841_CR80","doi-asserted-by":"publisher","first-page":"11128","DOI":"10.1038\/ncomms11128","volume":"7","author":"KR Healey","year":"2016","unstructured":"Healey KR, Zhao Y, Perez WB, Lockhart SR, Sobel JD, Farmakiotis D. Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance. Nat Commun. 2016;7:11128.","journal-title":"Nat Commun"},{"key":"2841_CR81","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1021\/cr300354g","volume":"113","author":"CP Satori","year":"2013","unstructured":"Satori CP, Henderson MM, Krautkramer EA, Kostal V, Distefano MM, Arriaga EA. Bioanalysis of eukaryotic organelles. Chem Rev. 2013;113:2733\u2013811.","journal-title":"Chem Rev"},{"key":"2841_CR82","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1517\/17425247.2015.1086745","volume":"13","author":"A Jhaveri","year":"2016","unstructured":"Jhaveri A, Torchilin V. Intracellular delivery of nanocarriers and targeting to subcellular organelles. Expert Opin Drug Deliv. 2016;13:49\u201370.","journal-title":"Expert Opin Drug Deliv"},{"key":"2841_CR83","doi-asserted-by":"publisher","first-page":"1802725","DOI":"10.1002\/adma.201802725","volume":"31","author":"WH Chen","year":"2019","unstructured":"Chen WH, Luo GF, Zhang XZ. Recent advances in subcellular targeted cancer therapy based on functional materials. Adv Mater. 2019;31:1802725.","journal-title":"Adv Mater"},{"key":"2841_CR84","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7326\/0003-4819-86-3-319","volume":"86","author":"BENNETT JE: Flucytosine","year":"1977","unstructured":"BENNETT JE: Flucytosine. Ann Intern Med. 1977;86:319\u201322.","journal-title":"Ann Intern Med"},{"key":"2841_CR85","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1128\/AAC.48.11.4377-4386.2004","volume":"48","author":"WW Hope","year":"2004","unstructured":"Hope WW, Tabernero L, Denning DW, Anderson MJ. Molecular mechanisms of primary resistance to Flucytosine in Candida albicans. Antimicrob Agents Chemother. 2004;48:4377\u201386.","journal-title":"Antimicrob Agents Chemother"},{"key":"2841_CR86","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1128\/JCM.43.8.3760-3768.2005","volume":"43","author":"CR Hsiao","year":"2005","unstructured":"Hsiao CR, Huang L, Bouchara J-P, Barton R, Li HC, Chang TC. Identification of medically important molds by an oligonucleotide array. J Clin Microbiol. 2005;43:3760\u20138.","journal-title":"J Clin Microbiol"},{"key":"2841_CR87","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4161\/viru.2.5.17035","volume":"2","author":"K Blecher","year":"2011","unstructured":"Blecher K, Nasir A, Friedman A. The growing role of nanotechnology in combating infectious disease. Virulence. 2011;2:395\u2013401.","journal-title":"Virulence"},{"key":"2841_CR88","doi-asserted-by":"publisher","first-page":"271","DOI":"10.4161\/viru.20328","volume":"3","author":"DO Schairer","year":"2012","unstructured":"Schairer DO, Chouake JS, Nosanchuk JD, Friedman AJ. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence. 2012;3:271\u20139.","journal-title":"Virulence"},{"key":"2841_CR89","doi-asserted-by":"publisher","first-page":"e00003","DOI":"10.1128\/aac.00003-23","volume":"67","author":"Y Qin","year":"2023","unstructured":"Qin Y, Wang J, Lv Q, Han B. Recent progress in Research on Mitochondrion-targeted antifungal drugs: a review. Antimicrob Agents Chemother. 2023;67:e00003\u201300023.","journal-title":"Antimicrob Agents Chemother"},{"key":"2841_CR90","doi-asserted-by":"publisher","first-page":"e02258","DOI":"10.1128\/mBio.02258-19","volume":"10","author":"D Murante","year":"2019","unstructured":"Murante D, Hogan DA. New mitochondrial targets in fungal pathogens. Mbio. 2019;10:e02258\u201302219.","journal-title":"Mbio"},{"key":"2841_CR91","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41580-021-00332-2","volume":"22","author":"E Kummer","year":"2021","unstructured":"Kummer E, Ban N. Mechanisms and regulation of protein synthesis in mitochondria. Nat Rev Mol Cell Biol. 2021;22:307\u201325.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2841_CR92","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1517\/17425240903236101","volume":"6","author":"GG D\u2019Souza","year":"2009","unstructured":"D\u2019Souza GG, Weissig V. Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet. Expert Opin Drug Deliv. 2009;6:1135\u201348.","journal-title":"Expert Opin Drug Deliv"},{"key":"2841_CR93","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biomaterials.2017.10.034","volume":"153","author":"D Zhang","year":"2018","unstructured":"Zhang D, Wen L, Huang R, Wang H, Hu X, Xing D. Mitochondrial specific photodynamic therapy by rare-earth nanoparticles mediated near-infrared graphene quantum dots. Biomaterials. 2018;153:14\u201326.","journal-title":"Biomaterials"},{"key":"2841_CR94","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.2217\/nnm-2020-0324","volume":"15","author":"E Piktel","year":"2020","unstructured":"Piktel E, Suprewicz \u0141, Depciuch J, Cie\u015bluk M, Chmielewska S, Durna\u015b B, Kr\u00f3l G, Wollny T, Deptu\u0142a P, Kochanowicz J. Rod-shaped gold nanoparticles exert potent candidacidal activity and decrease the adhesion of fungal cells. Nanomedicine. 2020;15:2733\u201352.","journal-title":"Nanomedicine"},{"key":"2841_CR95","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1742-4658.2012.08527.x","volume":"279","author":"J Hwang Is, Lee","year":"2012","unstructured":"Hwang Is, Lee J, Hwang JH, Kim KJ, Lee DG. Silver nanoparticles induce apoptotic cell death in Candida albicans through the increase of hydroxyl radicals. FEBS J. 2012;279:1327\u201338.","journal-title":"FEBS J"},{"key":"2841_CR96","doi-asserted-by":"crossref","unstructured":"McLellan CA, Vincent BM, Solis NV, Lancaster AK, Sullivan LB, Hartland CL, et al. Inhibiting mitochondrial phosphate transport as an unexploited antifungal strategy. Nat Chem Biol. 2018;14:135\u201341.","DOI":"10.1038\/nchembio.2534"},{"key":"2841_CR97","doi-asserted-by":"crossref","unstructured":"Yamashita K, Miyazaki T, Fukuda Y, Mitsuyama J, Saijo T, Shimamura S, et al. The novel arylamidine T-2307 selectively disrupts yeast mitochondrial function by inhibiting respiratory chain complexes. Antimicrob Agents Chemother. 2019;63:e00374-19.","DOI":"10.1128\/AAC.00374-19"},{"key":"2841_CR98","doi-asserted-by":"crossref","unstructured":"Wiederhold NP, Najvar LK, Fothergill AW, Bocanegra R, Olivo M, McCarthy DI, et al. The novel arylamidine T-2307 maintains in vitro and in vivo activity against echinocandin-resistant Candida albicans. Antimicrob Agents Chemother. 2015;59:1341\u20133.","DOI":"10.1128\/AAC.04228-14"},{"key":"2841_CR99","doi-asserted-by":"publisher","first-page":"7296","DOI":"10.1021\/acs.jmedchem.2c00274","volume":"65","author":"Y Wu","year":"2022","unstructured":"Wu Y, Jiang W, Cong Z, Chen K, She Y, Zhong C, Zhang W, Chen M, Zhou M, Shao N. An effective strategy to develop potent and selective antifungal agents from cell penetrating peptides in tackling drug-resistant invasive fungal infections. J Med Chem. 2022;65:7296\u2013311.","journal-title":"J Med Chem"},{"key":"2841_CR100","doi-asserted-by":"publisher","first-page":"7286","DOI":"10.1074\/jbc.274.11.7286","volume":"274","author":"EJ Helmerhorst","year":"1999","unstructured":"Helmerhorst EJ, Breeuwer P, van\u2019t Hof W, Walgreen-Weterings E, Oomen LC, Veerman EC, Amerongen AVN, Abee T. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J Biol Chem. 1999;274:7286\u201391.","journal-title":"J Biol Chem"},{"key":"2841_CR101","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","volume":"14","author":"UE Martinez-Outschoorn","year":"2017","unstructured":"Martinez-Outschoorn UE, Peiris-Pag\u00e9s M, Pestell RG, Sotgia F, Lisanti MP. Cancer metabolism: a therapeutic perspective. Nat Reviews Clin Oncol. 2017;14:11\u201331.","journal-title":"Nat Reviews Clin Oncol"},{"key":"2841_CR102","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.tips.2021.10.003","volume":"43","author":"S Wijnants","year":"2022","unstructured":"Wijnants S, Vreys J, Van Dijck P. Interesting antifungal drug targets in the central metabolism of Candida albicans. Trends Pharmacol Sci. 2022;43:69\u201379.","journal-title":"Trends Pharmacol Sci"},{"key":"2841_CR103","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fmicb.2020.00296","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, Zhang Z, Chen Z, Li Y, Su S, Sun S. Potential antifungal targets based on glucose metabolism pathways of Candida albicans. Front Microbiol. 2020;11:296.","journal-title":"Front Microbiol"},{"key":"2841_CR104","doi-asserted-by":"publisher","first-page":"00357","DOI":"10.1128\/mSphere.00357-17","volume":"2","author":"EM Vesely","year":"2017","unstructured":"Vesely EM, Williams RB, Konopka JB, Lorenz MC. N-Acetylglucosamine metabolism promotes survival of Candida albicans in the phagosome. Msphere. 2017;2:00357\u201300317.","journal-title":"Msphere"},{"key":"2841_CR105","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/08927014.2017.1392514","volume":"33","author":"R Alves","year":"2017","unstructured":"Alves R, Mota S, Silva S, Rodrigues F, Brown CP, Henriques AJ, Casal M, Paiva M. The carboxylic acid transporters Jen1 and Jen2 affect the architecture and fluconazole susceptibility of Candida albicans biofilm in the presence of lactate. Biofouling. 2017;33:943\u201354.","journal-title":"Biofouling"},{"key":"2841_CR106","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/j.1462-5822.2012.01813.x","volume":"14","author":"IV Ene","year":"2012","unstructured":"Ene IV, Adya AK, Wehmeier S, Brand AC, MacCallum DM, Gow NA, Brown AJ. Host carbon sources modulate cell wall architecture, drug resistance and virulence in a fungal pathogen. Cell Microbiol. 2012;14:1319\u201335.","journal-title":"Cell Microbiol"},{"key":"2841_CR107","doi-asserted-by":"publisher","first-page":"17289","DOI":"10.1021\/acsami.1c01748","volume":"13","author":"Y Ji","year":"2021","unstructured":"Ji Y, Han Z, Ding H, Xu X, Wang D, Zhu Y, An F, Tang S, Zhang H, Deng J. Enhanced eradication of bacterial\/fungi biofilms by glucose oxidase-modified magnetic nanoparticles as a potential treatment for persistent endodontic infections. ACS Appl Mater Interfaces. 2021;13:17289\u201399.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2841_CR108","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1091\/mbc.e09-01-0002","volume":"20","author":"A Rodaki","year":"2009","unstructured":"Rodaki A, Bohovych IM, Enjalbert B, Young T, Odds FC, Gow NA, Brown AJ. Glucose promotes stress resistance in the fungal pathogen Candida albicans. Mol Biol Cell. 2009;20:4845\u201355.","journal-title":"Mol Biol Cell"},{"key":"2841_CR109","doi-asserted-by":"crossref","unstructured":"Dietl A-M, Misslinger M, Aguiar MM, Ivashov V, Teis D, Pfister J, et al. The siderophore transporter Sit1 determines susceptibility to the antifungal VL-2397. Antimicrob Agents Chemother. 2019;63:e00807-19.","DOI":"10.1128\/AAC.00807-19"},{"key":"2841_CR110","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/ja.2016.107","volume":"70","author":"I Nakamura","year":"2017","unstructured":"Nakamura I, Yoshimura S, Masaki T, Takase S, Ohsumi K, Hashimoto M, Furukawa S, Fujie A. ASP2397: a novel antifungal agent produced by Acremonium Persicinum MF-347833. J Antibiot. 2017;70:45\u201351.","journal-title":"J Antibiot"},{"key":"2841_CR111","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.fgb.2015.02.008","volume":"81","author":"Q Yu","year":"2015","unstructured":"Yu Q, Jia C, Dong Y, Zhang B, Xiao C, Chen Y, Wang Y, Li X, Wang L, Zhang B. Candida albicans autophagy, no longer a bystander: its role in tolerance to ER stress-related antifungal drugs. Fungal Genet Biol. 2015;81:238\u201349.","journal-title":"Fungal Genet Biol"},{"key":"2841_CR112","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.tim.2014.07.001","volume":"22","author":"AJ Brown","year":"2014","unstructured":"Brown AJ, Brown GD, Netea MG, Gow NA. Metabolism impacts upon Candida immunogenicity and pathogenicity at multiple levels. Trends Microbiol. 2014;22:614\u201322.","journal-title":"Trends Microbiol"},{"key":"2841_CR113","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1128\/EC.00350-07","volume":"6","author":"HM Mora-Montes","year":"2007","unstructured":"Mora-Montes HM, Bates S, Netea MG, D\u00edaz-Jim\u00e9nez DF, L\u00f3pez-Romero E, Zinker S, Ponce-Noyola P, Kullberg BJ, Brown AJ, Odds FC. Endoplasmic reticulum \u03b1-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction. Eukaryot Cell. 2007;6:2184\u201393.","journal-title":"Eukaryot Cell"},{"key":"2841_CR114","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1042\/bst0311248","volume":"31","author":"F Lecomte","year":"2003","unstructured":"Lecomte F, Ismail N, High S. Making membrane proteins at the mammalian endoplasmic reticulum. Biochem Soc Trans. 2003;31:1248\u201352.","journal-title":"Biochem Soc Trans"},{"key":"2841_CR115","doi-asserted-by":"publisher","first-page":"4729","DOI":"10.1007\/s00018-020-03523-w","volume":"77","author":"C Almeida","year":"2020","unstructured":"Almeida C, Amaral MD. A central role of the endoplasmic reticulum in the cell emerges from its functional contact sites with multiple organelles. Cell Mol Life Sci. 2020;77:4729\u201345.","journal-title":"Cell Mol Life Sci"},{"key":"2841_CR116","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ejmech.2019.07.003","volume":"179","author":"R Elias","year":"2019","unstructured":"Elias R, Benhamou RI, Jaber QZ, Dorot O, Zada SL, Oved K, Pichinuk E, Fridman M. Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles. Eur J Med Chem. 2019;179:779\u201390.","journal-title":"Eur J Med Chem"},{"key":"2841_CR117","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1021\/acschembio.8b00782","volume":"13","author":"RI Benhamou","year":"2018","unstructured":"Benhamou RI, Jaber QZ, Herzog IM, Roichman Y, Fridman M. Fluorescent tracking of the endoplasmic reticulum in live pathogenic fungal cells. ACS Chem Biol. 2018;13:3325\u201332.","journal-title":"ACS Chem Biol"},{"key":"2841_CR118","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1002\/ange.201802509","volume":"130","author":"RI Benhamou","year":"2018","unstructured":"Benhamou RI, Bibi M, Berman J, Fridman M. Localizing antifungal drugs to the correct organelle can markedly enhance their efficacy. Angew Chem. 2018;130:6338\u201343.","journal-title":"Angew Chem"},{"key":"2841_CR119","doi-asserted-by":"publisher","first-page":"46614","DOI":"10.1021\/acsami.9b18388","volume":"11","author":"W Zhang","year":"2019","unstructured":"Zhang W, Yu M, Xi Z, Nie D, Dai Z, Wang J, Qian K, Weng H, Gan Y, Xu L. Cancer cell membrane-camouflaged nanorods with endoplasmic reticulum targeting for improved antitumor therapy. ACS Appl Mater Interfaces. 2019;11:46614\u201325.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2841_CR120","doi-asserted-by":"publisher","first-page":"27140","DOI":"10.1021\/acsami.5b07557","volume":"7","author":"Y Wang","year":"2015","unstructured":"Wang Y, Kaur G, Chen Y, Santos A, Losic D, Evdokiou A. Bioinert anodic alumina nanotubes for targeting of endoplasmic reticulum stress and autophagic signaling: a combinatorial nanotube-based drug delivery system for enhancing cancer therapy. ACS Appl Mater Interfaces. 2015;7:27140\u201351.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2841_CR121","doi-asserted-by":"publisher","first-page":"1800223","DOI":"10.1002\/smll.201800223","volume":"14","author":"L Shi","year":"2018","unstructured":"Shi L, Gao X, Yuan W, Xu L, Deng H, Wu C, Yang J, Jin X, Zhang C, Zhu X. Endoplasmic reticulum\u2013targeted fluorescent nanodot with large Stokes Shift for Vesicular Transport Monitoring and long-term bioimaging. Small. 2018;14:1800223.","journal-title":"Small"},{"key":"2841_CR122","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.biomaterials.2016.04.026","volume":"97","author":"X Ma","year":"2016","unstructured":"Ma X, Gong N, Zhong L, Sun J, Liang X-J. Future of nanotherapeutics: targeting the cellular sub-organelles. Biomaterials. 2016;97:10\u201321.","journal-title":"Biomaterials"},{"key":"2841_CR123","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.jconrel.2020.11.054","volume":"329","author":"Y Shi","year":"2021","unstructured":"Shi Y, Wang S, Wu J, Jin X, You J. Pharmaceutical strategies for endoplasmic reticulum-targeting and their prospects of application. J Controlled Release. 2021;329:337\u201352.","journal-title":"J Controlled Release"},{"key":"2841_CR124","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41392-022-01243-0","volume":"7","author":"J Yang","year":"2022","unstructured":"Yang J, Griffin A, Qiang Z, Ren J. Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology. Signal Transduct Target Therapy. 2022;7:379.","journal-title":"Signal Transduct Target Therapy"},{"key":"2841_CR125","doi-asserted-by":"publisher","first-page":"5018","DOI":"10.1021\/nn300571c","volume":"6","author":"J Wang","year":"2012","unstructured":"Wang J, Fang X, Liang W. Pegylated phospholipid micelles induce endoplasmic reticulum-dependent apoptosis of cancer cells but not normal cells. ACS Nano. 2012;6:5018\u201330.","journal-title":"ACS Nano"},{"key":"2841_CR126","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1126\/science.1118370","volume":"309","author":"LE Cowen","year":"2005","unstructured":"Cowen LE, Lindquist S. Hsp90 potentiates the Rapid Evolution of New traits: Drug Resistance in Diverse Fungi. Science. 2005;309:2185\u20139.","journal-title":"Science"},{"key":"2841_CR127","doi-asserted-by":"publisher","first-page":"e2001015","DOI":"10.1371\/journal.pbio.2001015","volume":"14","author":"R Schell","year":"2016","unstructured":"Schell R, Mullis M, Ehrenreich IM. Modifiers of the genotype\u2013phenotype map: Hsp90 and beyond. PLoS Biol. 2016;14:e2001015.","journal-title":"PLoS Biol"},{"key":"2841_CR128","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1021\/acs.jmedchem.9b00826","volume":"63","author":"DS Huang","year":"2019","unstructured":"Huang DS, Leblanc EV, Shekhar-Guturja T, Robbins N, Krysan DJ, Pizarro JC, Whitesell L, Cowen LE, Brown LE. Design and synthesis of fungal-selective resorcylate aminopyrazole Hsp90 inhibitors. J Med Chem. 2019;63:2139\u201380.","journal-title":"J Med Chem"},{"key":"2841_CR129","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41467-018-08248-w","volume":"10","author":"L Whitesell","year":"2019","unstructured":"Whitesell L, Robbins N, Huang DS, McLellan CA, Shekhar-Guturja T, Leblanc EV, Nation CS, Hui R, Hutchinson A, Collins C, et al. Structural basis for species-selective targeting of Hsp90 in a pathogenic fungus. Nat Commun. 2019;10:402.","journal-title":"Nat Commun"},{"key":"2841_CR130","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1056\/NEJMoa0801479","volume":"359","author":"JF San Miguel","year":"2008","unstructured":"San Miguel JF, Schlag R, Khuageva NK, Dimopoulos MA, Shpilberg O, Kropff M, Spicka I, Petrucci MT, Palumbo A, Samoilova OS. Bortezomib plus Melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med. 2008;359:906\u201317.","journal-title":"N Engl J Med"},{"key":"2841_CR131","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nchembio.744","volume":"8","author":"T Roemer","year":"2012","unstructured":"Roemer T, Davies J, Giaever G, Nislow C. Bugs, drugs and chemical genomics. Nat Chem Biol. 2012;8:46\u201356.","journal-title":"Nat Chem Biol"},{"key":"2841_CR132","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1021\/np2001573","volume":"74","author":"D Xu","year":"2011","unstructured":"Xu D, Ondeyka J, Harris GH, Zink D, Kahn JN, Wang H, Bills G, Platas G, Wang W, Szewczak AA. Isolation, structure, and biological activities of fellutamides C and D from an undescribed Metulocladosporiella (Chaetothyriales) using the genome-wide Candida albicans fitness test. J Nat Prod. 2011;74:1721\u201330.","journal-title":"J Nat Prod"},{"key":"2841_CR133","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.chembiol.2011.01.009","volume":"18","author":"T Roemer","year":"2011","unstructured":"Roemer T, Xu D, Singh SB, Parish CA, Harris G, Wang H, Davies JE, Bills GF. Confronting the challenges of natural product-based antifungal discovery. Chem Biol. 2011;18:148\u201364.","journal-title":"Chem Biol"},{"key":"2841_CR134","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3390\/jof7121016","volume":"7","author":"D Gutierrez-Gongora","year":"2021","unstructured":"Gutierrez-Gongora D, Geddes-McAlister J. From naturally-sourced protease inhibitors to new treatments for fungal infections. J Fungi. 2021;7:1016.","journal-title":"J Fungi"},{"key":"2841_CR135","doi-asserted-by":"publisher","first-page":"14228","DOI":"10.1038\/s41598-023-41281-4","volume":"13","author":"S W\u00f3jcik-Mieszawska","year":"2023","unstructured":"W\u00f3jcik-Mieszawska S, Lewtak K, Skwarek E, D\u0119bowski D, Gitlin-Domagalska A, Nowak J, Wydrych J, Pawelec J, Fio\u0142ka MJ. Autophagy of Candida albicans cells after the action of earthworm Venetin-1 nanoparticle with protease inhibitor activity. Sci Rep. 2023;13:14228.","journal-title":"Sci Rep"},{"key":"2841_CR136","doi-asserted-by":"publisher","first-page":"e2006872","DOI":"10.1371\/journal.pbio.2006872","volume":"16","author":"R Zarnowski","year":"2018","unstructured":"Zarnowski R, Sanchez H, Covelli AS, Dominguez E, Jaromin A, Bernhardt J, Mitchell KF, Heiss C, Azadi P, Mitchell A. Candida albicans biofilm\u2013induced vesicles confer drug resistance through matrix biogenesis. PLoS Biol. 2018;16:e2006872.","journal-title":"PLoS Biol"},{"key":"2841_CR137","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.mib.2013.04.002","volume":"16","author":"ML Rodrigues","year":"2013","unstructured":"Rodrigues ML, Franzen AJ, Nimrichter L, Miranda K. Vesicular mechanisms of traffic of fungal molecules to the extracellular space. Curr Opin Microbiol. 2013;16:414\u201320.","journal-title":"Curr Opin Microbiol"},{"key":"2841_CR138","doi-asserted-by":"publisher","first-page":"6235","DOI":"10.1038\/s41467-021-26525-z","volume":"12","author":"R Zarnowski","year":"2021","unstructured":"Zarnowski R, Noll A, Chevrette MG, Sanchez H, Jones R, Anhalt H, Fossen J, Jaromin A, Currie C, Nett JE. Coordination of fungal biofilm development by extracellular vesicle cargo. Nat Commun. 2021;12:6235.","journal-title":"Nat Commun"},{"key":"2841_CR139","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1126\/science.abd6919","volume":"370","author":"F Zhang","year":"2020","unstructured":"Zhang F, Zhao M, Braun DR, Ericksen SS, Piotrowski JS, Nelson J, Peng J, Ananiev GE, Chanana S, Barns K. A marine microbiome antifungal targets urgent-threat drug-resistant fungi. Science. 2020;370:974\u20138.","journal-title":"Science"},{"key":"2841_CR140","doi-asserted-by":"publisher","first-page":"e145123","DOI":"10.1172\/JCI145123","volume":"131","author":"M Zhao","year":"2021","unstructured":"Zhao M, Zhang F, Zarnowski R, Barns K, Jones R, Fossen J, Sanchez H, Rajski SR, Audhya A, Bugni TS. Turbinmicin inhibits Candida biofilm growth by disrupting fungal vesicle\u2013mediated trafficking. J Clin Investig. 2021;131:e145123.","journal-title":"J Clin Investig"},{"key":"2841_CR141","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1074\/jbc.275.3.1625","volume":"275","author":"GL Lukacs","year":"2000","unstructured":"Lukacs GL, Haggie P, Seksek O, Lechardeur D, Freedman N, Verkman A. Size-dependent DNA mobility in cytoplasm and nucleus. J Biol Chem. 2000;275:1625\u20139.","journal-title":"J Biol Chem"},{"key":"2841_CR142","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1083\/jcb.138.1.131","volume":"138","author":"O Seksek","year":"1997","unstructured":"Seksek O, Biwersi J, Verkman A. Translational diffusion of macromolecule-sized solutes in cytoplasm and nucleus. J Cell Biol. 1997;138:131\u201342.","journal-title":"J Cell Biol"},{"key":"2841_CR143","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","volume":"81","author":"M Hoenigl","year":"2021","unstructured":"Hoenigl M, Sprute R, Egger M, Arastehfar A, Cornely OA, Krause R, Lass-Fl\u00f6rl C, Prattes J, Spec A, Thompson GR. The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin. Drugs. 2021;81:1703\u201329.","journal-title":"Drugs"},{"key":"2841_CR144","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/jof6040261","volume":"6","author":"DJ Larwood","year":"2020","unstructured":"Larwood DJ. Nikkomycin Z\u2014ready to meet the promise? J Fungi. 2020;6:261.","journal-title":"J Fungi"},{"key":"2841_CR145","doi-asserted-by":"publisher","first-page":"120688","DOI":"10.1016\/j.ijpharm.2021.120688","volume":"603","author":"A Lipa-Castro","year":"2021","unstructured":"Lipa-Castro A, Nicolas V, Angelova A, Mekhloufi G, Prost B, Ch\u00e9ron M, Faivre V, Barratt G. Cochleate formulations of Amphotericin b designed for oral administration using a naturally occurring phospholipid. Int J Pharm. 2021;603:120688.","journal-title":"Int J Pharm"},{"key":"2841_CR146","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.3390\/molecules27092936","volume":"27","author":"I Fatima","year":"2022","unstructured":"Fatima I, Rasul A, Shah S, Saadullah M, Islam N, Khames A, Salawi A, Ahmed MM, Almoshari Y, Abbas G. Novasomes as nano-vesicular carriers to enhance topical delivery of fluconazole: a new approach to treat fungal infections. Molecules. 2022;27:2936.","journal-title":"Molecules"},{"key":"2841_CR147","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1128\/JCM.00618-09","volume":"47","author":"M Pfaller","year":"2009","unstructured":"Pfaller M, Messer S, Georgopapadakou N, Martell L, Besterman J, Diekema D. Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens. J Clin Microbiol. 2009;47:3797\u2013804.","journal-title":"J Clin Microbiol"},{"key":"2841_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42452-020-04103-0","volume":"3","author":"M G\u00f3mez-Garz\u00f3n","year":"2021","unstructured":"G\u00f3mez-Garz\u00f3n M, Guti\u00e9rrez-Casta\u00f1eda LD, Gil C, Escobar CH, Rozo AP, Gonz\u00e1lez ME, Sierra EV. Inhibition of the filamentation of Candida albicans by Borojoa patinoi silver nanoparticles. SN Appl Sci. 2021;3:1\u20138.","journal-title":"SN Appl Sci"},{"key":"2841_CR149","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ejim.2016.06.029","volume":"34","author":"S Antinori","year":"2016","unstructured":"Antinori S, Milazzo L, Sollima S, Galli M, Corbellino M. Candidemia and invasive candidiasis in adults: a narrative review. Eur J Intern Med. 2016;34:21\u20138.","journal-title":"Eur J Intern Med"},{"key":"2841_CR150","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/cmi.12369","volume":"17","author":"DD Thomson","year":"2015","unstructured":"Thomson DD, Wehmeier S, Byfield FJ, Janmey PA, Caballero-Lima D, Crossley A, et al. Contact\u2010induced apical asymmetry drives the thigmotropic responses of Candida albicans hyphae. Cell Microbiol. 2015;17:342\u201354.","journal-title":"Cell Microbiol"},{"key":"2841_CR151","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1126\/science.283.5407.1535","volume":"283","author":"JF Staab","year":"1999","unstructured":"Staab JF, Bradway SD, Fidel PL, Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science. 1999;283:1535\u20138.","journal-title":"Science"},{"key":"2841_CR152","doi-asserted-by":"publisher","first-page":"e1000217","DOI":"10.1371\/journal.ppat.1000217","volume":"4","author":"RS Almeida","year":"2008","unstructured":"Almeida RS, Brunke S, Albrecht A, Thewes S, Laue M, Edwards JE Jr, Filler SG, Hube B. The hyphal-associated adhesin and invasin Als3 of Candida albicans mediates iron acquisition from host ferritin. PLoS Pathog. 2008;4:e1000217.","journal-title":"PLoS Pathog"},{"key":"2841_CR153","doi-asserted-by":"publisher","first-page":"e1003741","DOI":"10.1371\/journal.ppat.1003741","volume":"9","author":"C Jimenez-Lopez","year":"2013","unstructured":"Jimenez-Lopez C, Lorenz MC. Fungal immune evasion in a model host\u2013pathogen interaction: Candida albicans versus macrophages. PLoS Pathog. 2013;9:e1003741.","journal-title":"PLoS Pathog"},{"key":"2841_CR154","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1128\/AAC.00628-06","volume":"50","author":"SP Saville","year":"2006","unstructured":"Saville SP, Lazzell AL, Bryant AP, Fretzen A, Monreal A, Solberg EO, Monteagudo C, Lopez-Ribot JL, Milne GT. Inhibition of filamentation can be used to treat disseminated candidiasis. Antimicrob Agents Chemother. 2006;50:3312\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"2841_CR155","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1128\/EC.3.4.900-909.2004","volume":"3","author":"A Brand","year":"2004","unstructured":"Brand A, MacCallum DM, Brown AJ, Gow NA, Odds FC. Ectopic expression of URA3 can influence the virulence phenotypes and proteome of Candida albicans but can be overcome by targeted reintegration of URA3 at the RPS10 locus. Eukaryot Cell. 2004;3:900\u20139.","journal-title":"Eukaryot Cell"},{"key":"2841_CR156","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pdpdt.2017.12.001","volume":"21","author":"AP Pinto","year":"2018","unstructured":"Pinto AP, Rosseti IB, Carvalho ML, da Silva BGM, Alberto-Silva C, Costa MS. Photodynamic antimicrobial chemotherapy (PACT), using Toluidine blue O inhibits the viability of biofilm produced by Candida albicans at different stages of development. Photodiagn Photodyn Ther. 2018;21:182\u20139.","journal-title":"Photodiagn Photodyn Ther"},{"key":"2841_CR157","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10103-017-2344-1","volume":"33","author":"ML Carvalho","year":"2018","unstructured":"Carvalho ML, Pinto AP, Raniero LJ, Costa MS. Biofilm formation by Candida albicans is inhibited by photodynamic antimicrobial chemotherapy (PACT), using chlorin e6: increase in both ROS production and membrane permeability. Lasers Med Sci. 2018;33:647\u201353.","journal-title":"Lasers Med Sci"},{"key":"2841_CR158","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nrmicro1818","volume":"6","author":"L Cegelski","year":"2008","unstructured":"Cegelski L, Marshall GR, Eldridge GR, Hultgren SJ. The biology and future prospects of antivirulence therapies. Nat Rev Microbiol. 2008;6:17\u201327.","journal-title":"Nat Rev Microbiol"},{"key":"2841_CR159","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrd.2017.23","volume":"16","author":"SW Dickey","year":"2017","unstructured":"Dickey SW, Cheung GY, Otto M. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance. Nat Rev Drug Discovery. 2017;16:457\u201371.","journal-title":"Nat Rev Drug Discovery"},{"key":"2841_CR160","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrmicro3232","volume":"12","author":"RC Allen","year":"2014","unstructured":"Allen RC, Popat R, Diggle SP, Brown SP. Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol. 2014;12:300\u20138.","journal-title":"Nat Rev Microbiol"},{"key":"2841_CR161","first-page":"452","volume":"90","author":"J Henderson","year":"1964","unstructured":"Henderson J, Nickerson JF. Bacterial endocarditis with Candida albicans superinfection. Can Med Assoc J. 1964;90:452.","journal-title":"Can Med Assoc J"},{"key":"2841_CR162","doi-asserted-by":"publisher","first-page":"myac030","DOI":"10.1093\/mmy\/myac030","volume":"60","author":"D Ara\u00fajo","year":"2021","unstructured":"Ara\u00fajo D, Gaspar R, Mil-Homens D, Henriques M, Silva BF, Silva S. Cationic lipid-based formulations for encapsulation and delivery of anti-EFG1 2\u2032 O MethylRNA oligomer. Med Mycol. 2021;60:myac030.","journal-title":"Med Mycol"},{"key":"2841_CR163","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/mmy\/myab033","volume":"59","author":"A Barbosa","year":"2021","unstructured":"Barbosa A, Ara\u00fajo D, Henriques M, Silva S. The combined application of the anti-RAS1 and anti-RIM101 2\u2019-O MethylRNA oligomers enhances Candida albicans filamentation control. Med Mycol. 2021;59:1024\u201331.","journal-title":"Med Mycol"},{"key":"2841_CR164","doi-asserted-by":"publisher","first-page":"777613","DOI":"10.3389\/fimmu.2022.777613","volume":"13","author":"M Zhao","year":"2022","unstructured":"Zhao M, Zhang M, Xu K, Wu K, Xie R, Li R, Wang Q, Liu W, Wang W, Wang X. Antimicrobial effect of extracellular vesicles derived from human oral mucosal epithelial cells on candida albicans. Front Immunol. 2022;13:777613.","journal-title":"Front Immunol"},{"key":"2841_CR165","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1099\/jmm.0.006841-0","volume":"58","author":"KA Toenjes","year":"2009","unstructured":"Toenjes KA, Stark BC, Brooks KM, Johnson DI. Inhibitors of cellular signalling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans. J Med Microbiol. 2009;58:779\u201390.","journal-title":"J Med Microbiol"},{"key":"2841_CR166","doi-asserted-by":"publisher","first-page":"942","DOI":"10.4014\/jmb.0911.11014","volume":"20","author":"K Okamoto-Shibayama","year":"2010","unstructured":"Okamoto-Shibayama K, Sato Y, Azuma T. Resveratrol impaired the morphological transition of Candida albicans under various hyphae-inducing conditions. J Microbiol Biotechnol. 2010;20:942\u20135.","journal-title":"J Microbiol Biotechnol"},{"key":"2841_CR167","doi-asserted-by":"publisher","first-page":"111617","DOI":"10.1016\/j.colsurfb.2021.111617","volume":"200","author":"V Rajasekar","year":"2021","unstructured":"Rajasekar V, Darne P, Prabhune A, Kao RY, Solomon AP, Ramage G, Samaranayake L, Neelakantan P. A curcumin-sophorolipid nanocomplex inhibits Candida albicans filamentation and biofilm development. Colloids Surf B. 2021;200:111617.","journal-title":"Colloids Surf B"},{"key":"2841_CR168","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.taap.2017.03.004","volume":"322","author":"M Zhang","year":"2017","unstructured":"Zhang M, Chang W, Shi H, Zhou Y, Zheng S, Li Y, Li L, Lou H. Biatriosporin D displays anti-virulence activity through decreasing the intracellular cAMP levels. Toxicol Appl Pharmcol. 2017;322:104\u201312.","journal-title":"Toxicol Appl Pharmcol"},{"key":"2841_CR169","doi-asserted-by":"publisher","first-page":"23575","DOI":"10.1038\/srep23575","volume":"6","author":"F Haque","year":"2016","unstructured":"Haque F, Alfatah M, Ganesan K, Bhattacharyya MS. Inhibitory effect of sophorolipid on Candida albicans biofilm formation and hyphal growth. Sci Rep. 2016;6:23575.","journal-title":"Sci Rep"},{"key":"2841_CR170","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.micres.2015.06.009","volume":"179","author":"P Nithyanand","year":"2015","unstructured":"Nithyanand P, Shafreen RMB, Muthamil S, Pandian SK. Usnic acid inhibits biofilm formation and virulent morphological traits of Candida albicans. Microbiol Res. 2015;179:20\u20138.","journal-title":"Microbiol Res"},{"key":"2841_CR171","doi-asserted-by":"crossref","unstructured":"do Nascimento Dias J, de Souza Silva C, de Ara\u00fajo AR, Souza JMT, de Holanda Veloso Junior PH, Cabral WF, et al. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells. Sci Rep. 2020;10:10327.","DOI":"10.1038\/s41598-020-67041-2"},{"key":"2841_CR172","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1080\/08927014.2020.1730333","volume":"36","author":"Y-G Kim","year":"2020","unstructured":"Kim Y-G, Lee J-H, Park JG, Lee J. Inhibition of Candida albicans and Staphylococcus aureus biofilms by centipede oil and linoleic acid. Biofouling. 2020;36:126\u201337.","journal-title":"Biofouling"},{"key":"2841_CR173","doi-asserted-by":"crossref","unstructured":"Iadnut A, Mamoon K, Thammasit P, Pawichai S, Tima S, Preechasuth K, et al. In vitro antifungal and antivirulence activities of biologically synthesized ethanolic extract of propolis-loaded PLGA nanoparticles against Candida albicans. Evid Based Complementary Altern Med. 2019;2019:3715481.","DOI":"10.1155\/2019\/3715481"},{"key":"2841_CR174","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1080\/21691401.2018.1439837","volume":"46","author":"M Jalal","year":"2018","unstructured":"Jalal M, Ansari MA, Ali SG, Khan HM, Rehman S. Anticandidal activity of bioinspired ZnO NPs: effect on growth, cell morphology and key virulence attributes of Candida species. Artif Cells Nanomed Biotechnol. 2018;46:912\u201325.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"2841_CR175","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.2147\/IJN.S210449","volume":"14","author":"M Jalal","year":"2019","unstructured":"Jalal M, Ansari MA, Alzohairy MA, Ali SG, Khan HM, Almatroudi A, Siddiqui MI. Anticandidal activity of biosynthesized silver nanoparticles: effect on growth, cell morphology, and key virulence attributes of Candida species. Int J Nanomed. 2019;14:4667\u201379.","journal-title":"Int J Nanomed"},{"key":"2841_CR176","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/nrmicro2636","volume":"9","author":"PE Sudbery","year":"2011","unstructured":"Sudbery PE. Growth of Candida albicans hyphae. Nat Rev Microbiol. 2011;9:737\u201348.","journal-title":"Nat Rev Microbiol"},{"key":"2841_CR177","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.fgb.2011.04.002","volume":"48","author":"T-L Han","year":"2011","unstructured":"Han T-L, Cannon RD, Villas-B\u00f4as SG. The metabolic basis of Candida albicans morphogenesis and quorum sensing. Fungal Genet Biol. 2011;48:747\u201363.","journal-title":"Fungal Genet Biol"},{"key":"2841_CR178","doi-asserted-by":"publisher","first-page":"6699","DOI":"10.1038\/s41467-021-27034-9","volume":"12","author":"X Ding","year":"2021","unstructured":"Ding X, Kambara H, Guo R, Kanneganti A, Acosta-Zald\u00edvar M, Li J, Liu F, Bei T, Qi W, Xie X. Inflammasome-mediated GSDMD activation facilitates escape of Candida albicans from macrophages. Nat Commun. 2021;12:6699.","journal-title":"Nat Commun"},{"key":"2841_CR179","doi-asserted-by":"publisher","first-page":"e02152","DOI":"10.1128\/AAC.02152-18","volume":"63","author":"S Puri","year":"2019","unstructured":"Puri S, Kumar R, Rojas IG, Salvatori O, Edgerton M. Iron chelator deferasirox reduces Candida albicans invasion of oral epithelial cells and infection levels in murine oropharyngeal candidiasis. Antimicrob Agents Chemother. 2019;63:e02152\u201302118.","journal-title":"Antimicrob Agents Chemother"},{"key":"2841_CR180","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1139\/cjm-2018-0337","volume":"65","author":"W Sun","year":"2019","unstructured":"Sun W, Zhang L, Lu X, Feng L, Sun S. The synergistic antifungal effects of sodium phenylbutyrate combined with azoles against Candida albicans via the regulation of the Ras\u2013cAMP\u2013PKA signalling pathway and virulence. Can J Microbiol. 2019;65:105\u201315.","journal-title":"Can J Microbiol"},{"key":"2841_CR181","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/mmi.13681","volume":"105","author":"C Cao","year":"2017","unstructured":"Cao C, Wu M, Bing J, Tao L, Ding X, Liu X, Huang G. Global regulatory roles of the c AMP\/PKA pathway revealed by phenotypic, transcriptomic and phosphoproteomic analyses in a null mutant of the PKA catalytic subunit in C andida albicans. Mol Microbiol. 2017;105:46\u201364.","journal-title":"Mol Microbiol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02841-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02841-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02841-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T17:04:45Z","timestamp":1726506285000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02841-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":181,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2841"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02841-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"13 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"568"}}